Please try another search
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to create biologics for patients. Its integrated drug creation platform is designed to improve upon traditional biologic drug discovery by using AI to simultaneously optimize multiple drug characteristics that may be important to development and therapeutic benefit. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Name | Age | Since | Title |
---|---|---|---|
Karen K. McGinnis | 56 | 2020 | Lead Independent Director |
Daniel A. Rabinovitsj | 58 | 2022 | Independent Director |
Amrit Nagpal | 48 | 2020 | Independent Director |
Joseph Sirosh | 54 | 2022 | Independent Director |
Timothy K. Lu | 42 | 2023 | Member of Scientific Advisory Board |
Victor Greiff | - | 2023 | Member of Scientific Advisory Board |
Hubert Truebel | - | 2023 | Member of Scientific Advisory Board |
Sean McClain | 34 | 2011 | Founder, CEO, President & Director |
Andreas Busch | 61 | 2022 | Chief Innovation Officer & Member of Scientific Advisory Board |
François Adrianus van Houten | 64 | 2023 | Independent Director |
Menelas Nicolas Pangalos | 57 | 2024 | Independent Director & Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review